Research Publications

Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.

SCV-07 (SciClone Pharmaceuticals/Verta).

Kinetics of hepatitis C virus reinfection after liver transplantation.

Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life.

A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.

An urgency to identify and treat chronic hepatitis C.

Helminthic Infections of the Liver.

The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA.

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.